UnitedHealth: A Timely Buy as Operational Fixes Start to Show
UnitedHealth ($UNH) has been punished since last year's peak, but the company still generates healthy free cash flow ($16.1B), pays a 3%+ dividend, and is trading at a reasonable multiple (PE ~21). Technicals and short-interest dynamics favor a recovery. This trade idea lays out an entry, stop and target for a long-term turnaround play over the nex…